Passage Summary: Critics think making copycat versions of existing medicines is a waste of resources. However, the author argues these copies are actually good because they can make medicine more affordable for consumers.

Conclusion: The development of 'me too' drugs provides a genuine benefit to the public.

Reasoning: These duplicate medications introduce competition into the pharmaceutical market, which can drive down the prices of the original drugs they mimic.

Analysis: The argument relies on the assumption that price reduction is a significant enough benefit to justify the existence of these drugs. To strengthen this, we want to see evidence that these price drops are substantial or that they are a primary concern for consumers. Look for an answer that reinforces the link between the market entry of these drugs and a tangible, positive outcome for the people buying them. If we can show that price is the most important factor for consumer benefit, the argument becomes much more robust.